These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 1626861)

  • 1. Immunization of cattle with an inactivated polyvalent vaccine against anaplasmosis and babesiosis.
    Montenegro-James S; Toro M; Leon E; Guillen AT; Lopez R; Lopez W
    Ann N Y Acad Sci; 1992 Jun; 653():112-21. PubMed ID: 1626861
    [No Abstract]   [Full Text] [Related]  

  • 2. Attenuated trivalent vaccine against babesiosis and anaplasmosis in Colombia.
    Benavides E; Vizcaino O; Britto CM; Romero A; Rubio A
    Ann N Y Acad Sci; 2000; 916():613-6. PubMed ID: 11193685
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular basis for vaccine development against anaplasmosis and babesiosis.
    Palmer GH; McElwain TF
    Vet Parasitol; 1995 Mar; 57(1-3):233-53. PubMed ID: 7597787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a frozen trivalent attenuated vaccine against Babesiosis and anaplasmosis in Brazil.
    Vidotto O; Barbosa CS; Andrade GM; Machado RZ; da Rocha MA; Silva SS
    Ann N Y Acad Sci; 1998 Jun; 849():420-3. PubMed ID: 9668502
    [No Abstract]   [Full Text] [Related]  

  • 5. Tick-borne diseases of cattle in Paraguay. II. Immunisation against anaplasmosis and babesiosis.
    Payne RC; Osorio O; Ybañez A
    Trop Anim Health Prod; 1990 May; 22(2):101-8. PubMed ID: 2196724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunisation of smallholder dairy cattle against anaplasmosis and babesiosis in Malawi.
    Tjornehoj K; Lawrence JA; Kafuwa PT; Whiteland AP; Chimera BA
    Trop Anim Health Prod; 1997 May; 29(2):77-82. PubMed ID: 9203307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subunit vaccines for complex tick-borne pathogens: dream or reality?
    Morrison WI
    Br Vet J; 1996 Nov; 152(6):617-9. PubMed ID: 8979420
    [No Abstract]   [Full Text] [Related]  

  • 8. Emerging perspectives in the research of bovine babesiosis and anaplasmosis.
    Suarez CE; Noh S
    Vet Parasitol; 2011 Aug; 180(1-2):109-25. PubMed ID: 21684084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Australian frozen vaccines for the control of babesiosis and anaplasmosis in cattle--a review.
    Dalgliesh RJ; Jorgensen WK; de Vos AJ
    Trop Anim Health Prod; 1990 Feb; 22(1):44-52. PubMed ID: 2181745
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessment of tetracycline and Babesia culture supernatant as prophylactics for moderating reactions in cattle to live Babesia and Anaplasma vaccines.
    Jorgensen WK; Bock RE; Kingston TG; de Vos AJ; Waldron SJ
    Aust Vet J; 1993 Jan; 70(1):35-6. PubMed ID: 8460988
    [No Abstract]   [Full Text] [Related]  

  • 11. Post-thawing viability of vaccines for bovine babesiosis and anaplasmosis cryopreserved with glycerol.
    Mangold AJ; Aguirre DH; Guglielmone AA
    Vet Parasitol; 1990 Nov; 37(3-4):301-6. PubMed ID: 2267730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunodiagnosis of and immunoprophylaxis against the haemoparasites Babesia sp. and Anaplasma sp. in domestic animals.
    Wright IG
    Rev Sci Tech; 1990 Jun; 9(2):345-56. PubMed ID: 2132684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological evidence of exposure to tick fever organisms in young cattle on Queensland dairy farms.
    Sserugga JN; Jonsson NN; Bock RE; More SJ
    Aust Vet J; 2003 Mar; 81(3):147-52. PubMed ID: 15080428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospects for subunit vaccines against tick-borne diseases.
    Musoke AJ; Palmer GH; McElwain TF; Nene V; McKeever D
    Br Vet J; 1996 Nov; 152(6):621-39. PubMed ID: 8979421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunity following use of Australian tick fever vaccine: a review of the evidence.
    Bock RE; de Vos AJ
    Aust Vet J; 2001 Dec; 79(12):832-9. PubMed ID: 11837905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of cattle responses to mono-specific or combined inoculations with Babesia bigemina and Babesia bovis vaccine strains.
    Viseras J; Lugaresi CI; Volpogni MM; Guglielmone AA
    Parasite; 1999 Mar; 6(1):67-9. PubMed ID: 10229940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methods currently used for the control of anaplasmosis and babesiosis: their validity and proposals for future control strategies.
    Lawrence JA; de Vos AJ
    Parassitologia; 1990 Apr; 32(1):63-71. PubMed ID: 2284136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Babesial antibody dynamics after cattle immunisation with live vaccines, measured with an indirect immunofluorescence test.
    Guglielmone AA; Lugaresi CI; Volpogni MM; Anziani OS; Vanzini VR
    Vet Parasitol; 1997 Jun; 70(1-3):33-9. PubMed ID: 9195707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming constraints to meeting increased demand for Babesia bigemina vaccine in Australia.
    Standfast NF; Bock RE; Wiecek MM; deVos AJ; Jorgensen WK; Kingston TG
    Vet Parasitol; 2003 Jul; 115(3):213-22. PubMed ID: 12935736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of an Australian Babesia bovis vaccine strain in Malawi.
    Lawrence JA; Malika J; Whiteland AP; Kafuwa P
    Vet Rec; 1993 Mar; 132(12):295-6. PubMed ID: 8470344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.